We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+1.51%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$40.7B
AUM Growth
-$514M
(-1.2%)
Cap. Flow
-$511M
Cap. Flow
% of AUM
-1.26%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
2,385
New
224
Increased
794
Reduced
1,083
Closed
195
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$348M |
| 2 |
LyondellBasell Industries
LYB
|
+$251M |
| 3 |
Pfizer
PFE
|
+$244M |
| 4 |
Fidelity National Information Services
FIS
|
+$179M |
| 5 |
Amcor
AMCR
|
+$121M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$427M |
| 2 |
Kimberly-Clark
KMB
|
+$279M |
| 3 |
Procter & Gamble
PG
|
+$253M |
| 4 |
WP
Worldpay, Inc.
WP
|
+$194M |
| 5 |
General Mills
GIS
|
+$185M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17% |
| 2 | Technology | 14.79% |
| 3 | Financials | 10.73% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Communication Services | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Danaher
DHR
$142B
| $63.7M | 0.16% |
497,762
-25,339
| -5% | -$3.17M |
|
152
Edwards Lifesciences
EW
$49.2B
| $63.7M | 0.16% |
868,962
-78,276
| -8% | -$5.5M |
|
153
Teradyne
TER
$52B
| $62.5M | 0.15% |
1,079,417
-82,446
| -7% | -$4.37M |
|
154
Baidu
BIDU
$35.6B
| $62.3M | 0.15% |
606,631
-45,051
| -7% | -$4.84M |
|
155
Advanced Micro Devices
AMD
$700B
| $62.2M | 0.15% |
2,145,901
-87,656
| -4% | -$2.75M |
|
156
Amgen
AMGN
$211B
| $62M | 0.15% |
320,485
-2,047
| -0.6% | -$393K |
|
157
Intel
INTC
$419B
| $61.7M | 0.15% |
1,197,100
-509,354
| -30% | -$25M |
|
158
Marvell Technology
MRVL
$149B
| $60.9M | 0.15% |
2,438,591
+25,893
| +1% | +$650K |
|
159
Trex
TREX
$4.39B
| $60.7M | 0.15% |
1,334,218
+57,652
| +5% | +$2.33M |
|
160
Brown & Brown
BRO
$25.3B
| $60.3M | 0.15% |
1,671,234
-143,884
| -8% | -$5.15M |
|
161
Silicon Laboratories
SLAB
$7.17B
| $60.2M | 0.15% |
540,734
-65,227
| -11% | -$7.06M |
|
162
HDFC Bank
HDB
$123B
| $60.2M | 0.15% |
2,109,844
-576,636
| -21% | -$16.4M |
|
163
Charter Communications
CHTR
$17.2B
| $60.1M | 0.15% |
145,816
+53,184
| +57% | +$21.5M |
|
164
British American Tobacco
BTI
$136B
| $59.7M | 0.15% |
1,617,053
-1,324,900
| -45% | -$48.5M |
|
165
AerCap
AER
$23.7B
| $59.2M | 0.15% |
1,081,238
+899
| +0.1% | +$47.5K |
|
166
Bio-Rad Laboratories Class A
BIO
$8.78B
| $59M | 0.15% |
177,429
-4,212
| -2% | -$1.37M |
|
167
Illumina
ILMN
$29.2B
| $58.7M | 0.14% |
198,237
-258,032
| -57% | -$76.1M |
|
|
Y
168
DELISTED
Alleghany Corp
Y
| $58.6M | 0.14% |
73,483
+9,862
| +16% | +$7.26M |
|
169
Comcast
CMCSA
$87.6B
| $58.5M | 0.14% |
1,297,926
-32,155
| -2% | -$1.42M |
|
170
Weibo
WB
$1.98B
| $58.4M | 0.14% |
1,304,869
+44,825
| +4% | +$1.9M |
|
171
Applied Materials
AMAT
$356B
| $58M | 0.14% |
1,162,608
+906,650
| +354% | +$43.8M |
|
|
ZGNX
172
DELISTED
Zogenix, Inc.
ZGNX
| $57.1M | 0.14% |
1,426,772
+214,995
| +18% | +$9.91M |
|
173
Community Bank
CBU
$3.42B
| $57M | 0.14% |
924,174
-62,572
| -6% | -$3.95M |
|
174
Floor & Decor
FND
$6B
| $57M | 0.14% |
1,114,200
-25,800
| -2% | -$1.16M |
|
175
EOG Resources
EOG
$77.4B
| $56.7M | 0.14% |
763,893
+227,676
| +42% | +$18.5M |
|
Similar funds
Federated Hermes's Q3 2019 Portfolio in Review
As of Q3 2019, Federated Hermes held 2,385 positions worth $40.7B, down 1.2% from $41.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Federated Hermes's Q3 2019 filing shows 224 new, 794 increased, 1,083 reduced and 195 closed positions. Its largest new stake was Medallia, Inc.: 852,063 shares worth $23.4M. The largest sale was Crown Castle, an estimated $427M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q3 2019 buy was Medallia, Inc.: 852,063 shares worth $23.4M.
- Federated Hermes added most to Gilead Sciences in Q3 2019, an estimated $348M increase.
- Federated Hermes's biggest Q3 2019 reduction was Crown Castle, cutting an estimated $427M.
- Federated Hermes fully exited Worldpay, Inc. in Q3 2019, selling an estimated $194M.
- Federated Hermes's ten largest holdings make up 17% of its $40.7B portfolio in Q3 2019.
- Federated Hermes opened 224 new positions and closed 195 in Q3 2019.
- Federated Hermes's portfolio value fell 1.2% quarter-over-quarter to $40.7B.
Based on Federated Hermes's 13F filing for Q3 2019, filed 14 Nov 2019.